Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines—Analysis with mathematical models

Bioorganic & Medicinal Chemistry
2013.0

Abstract

Caffeine (CAF) and other methylxanthines (MTX) may interact directly with several aromatic, intercalating ligands through mixed stacking aggregation. Formation of such stacking hetero-complexes may decrease their free form concentration and, in consequence, diminish their biological activity, which is often related to their direct interaction with DNA. In this paper interactions of acridine mutagen (ICR191) with DNA in the presence of three MTX: caffeine (CAF), pentoxifylline (PTX) and theophylline (TH) are investigated. Several mathematical models are used to calculate all association constant values and every component concentration in each analyzed mixture. Model McGhee-von Hippel is used to analyze ligand-DNA interaction, and model Zdunek et al.--to analyze ligand-MTX interactions. Finally, two distinct mathematical models are employed to analyze three-component mixture containing ligand, MTX and DNA molecules. The first model describes possible interactions of ligand with DNA and MTX, and rejects direct MTX interactions with DNA. The second model describes all interactions mentioned above and, additionally, allows MTX to interact directly with DNA. Results obtained using these models are similar. However, correspondence of theoretical results to experimental data is better for the first model than the second one. In this paper possible interactions of ICR191 with eukaryotic cell chromatin are also analyzed, showing that CAF reduces acridine mutagen potential to interact directly with cell chromatin. Additionally, it is demonstrated that MTX inhibit mutagenic activity of ICR191 in a dose-dependent manner. Furthermore, biological activity of ICR191-MTX mixtures corresponds with concentration of free mutagen form calculated using appropriate mathematical model.

Knowledge Graph

Similar Paper

Modulation of acridine mutagen ICR191 intercalation to DNA by methylxanthines—Analysis with mathematical models
Bioorganic & Medicinal Chemistry 2013.0
Structural Basis for the Binding Affinity of Xanthines with the DNA Intercalator Acridine Orange
Journal of Medicinal Chemistry 2001.0
Impaired mutagenic activities of MPDP+ (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP+ (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines
Bioorganic & Medicinal Chemistry 2007.0
Effect of methyl substitution in a ligand on the selectivity and binding affinity for a nucleobase: A case study with isoxanthopterin and its derivatives
Bioorganic & Medicinal Chemistry 2009.0
Synthesis, chemical characterization of novel 1,3-dimethyl acridones as cytotoxic agents, and their DNA-binding studies
Medicinal Chemistry Research 2010.0
Novel Acridine-Triazenes as Prototype Combilexins: Synthesis, DNA Binding, and Biological Activity
Journal of Medicinal Chemistry 1995.0
Potentiation of cADPR-Induced Ca<sup>2+</sup>-Release by Methylxanthine Analogues
Journal of Medicinal Chemistry 1999.0
Frameshift mutations induced by four isomeric nitroacridines and their des-nitro counterpart in thelacZ reversion assay inEscherichia coli
Environmental and Molecular Mutagenesis 2006.0
1-[(ω-Aminoalkyl)amino]-4-[N-(ω-aminoalkyl)carbamoyl]-9-oxo-9,10-dihydro- acridines as Intercalating Cytotoxic Agents:  Synthesis, DNA Binding, and Biological Evaluation
Journal of Medicinal Chemistry 1997.0
Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine
Biochemical and Biophysical Research Communications 2004.0